According to the report, gene, protein and cell therapies to induce arteriogenesis (angiogenesis) are the hot new areas of research for both IC and CLI. Arteriogenesis, also known as bio-bypass, is the process in which the body grows collateral vessels to bypass an obstruction.
Mary Yost, president of Sage, said: “Over the past five years, the expansion of the PAD treatment market has been driven almost entirely by the medical device industry with the introduction of innovative endovascular devices.”